Sam-A Pharm Company Overview
- Year Founded
-
1945
- Status
-
Public
- Employees
-
316
- Stock Symbol
-
009300
- Share Price
-
$13.19
- (As of Tuesday Closing)
Sam-A Pharm Company General Information
Description
Sam-A-Pharm Co Ltd is a South Korea based company engages in the manufacturing of pharmaceutical products. Its products include medicines for cold and fever, inflammatory, allergy, nutrition, and respiratory and digestive systems.
Contact Information
Website
www.samapharm.co.krCorporate Office
- 49 Donghwagongdan-ro
- Munmak-eup
- Wonju, Gangwon 26365
- South Korea
Corporate Office
- 49 Donghwagongdan-ro
- Munmak-eup
- Wonju, Gangwon 26365
- South Korea
Sam-A Pharm Company Stock Performance
As of 08-Jul-2025, Sam-A Pharm Company’s stock price is $13.19. Its current market cap is $80.5M with 6.1M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $13.19 | $13.11 | $10.44 - $27.49 | $80.5M | 6.1M | 7.82K | $2.23 |
Sam-A Pharm Company Financials Summary
As of 31-Mar-2025, Sam-A Pharm Company has a trailing 12-month revenue of $64.6M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 16,678 | 25,943 | 24,406 | 33,921 |
| Revenue | 64,610 | 70,051 | 74,352 | 63,229 |
| EBITDA | 21,153 | 20,968 | 21,375 | 14,874 |
| Net Income | 13,621 | 16,182 | 16,348 | 9,219 |
| Total Assets | 174,019 | 168,865 | 179,492 | 160,897 |
| Total Debt | 7,750 | 8,751 | 9,055 | 1,401 |
Sam-A Pharm Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sam-A Pharm Company Patents
Sam-A Pharm Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3305282-A2 | Composition of pranlukast-containing solid preparation with improved bioavailability and method for preparing same | Inactive | 01-Jun-2015 | ||
| JP-2018516942-A | Composition of pranlukast-containing solid preparation with improved bioavailability and method for producing the same | Pending | 01-Jun-2015 | ||
| EP-2942052-A1 | Novel fast-dissolving granule formulation having improved solubility | Inactive | 07-Jan-2013 | ||
| EP-2942052-A4 | Novel fast-dissolving granule formulation having improved solubility | Inactive | 07-Jan-2013 | ||
| US-6214868-B1 | Side effect reduction, effectiveness | Inactive | 29-Feb-2000 | A61K31/35 |
Sam-A Pharm Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sam-A Pharm Company FAQs
-
When was Sam-A Pharm Company founded?
Sam-A Pharm Company was founded in 1945.
-
Where is Sam-A Pharm Company headquartered?
Sam-A Pharm Company is headquartered in Wonju, South Korea.
-
What is the size of Sam-A Pharm Company?
Sam-A Pharm Company has 316 total employees.
-
What industry is Sam-A Pharm Company in?
Sam-A Pharm Company’s primary industry is Pharmaceuticals.
-
Is Sam-A Pharm Company a private or public company?
Sam-A Pharm Company is a Public company.
-
What is Sam-A Pharm Company’s stock symbol?
The ticker symbol for Sam-A Pharm Company is 009300.
-
What is the current stock price of Sam-A Pharm Company?
As of 08-Jul-2025 the stock price of Sam-A Pharm Company is $13.19.
-
What is the current market cap of Sam-A Pharm Company?
The current market capitalization of Sam-A Pharm Company is $80.5M.
-
What is Sam-A Pharm Company’s current revenue?
The trailing twelve month revenue for Sam-A Pharm Company is $64.6M.
-
What is Sam-A Pharm Company’s annual earnings per share (EPS)?
Sam-A Pharm Company’s EPS for 12 months was $2.23.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
